Difference between revisions of "ERF of omega-3 fatty acids on CVD risk in adults"

From Testiwiki
Jump to: navigation, search
(→‎Result)
(→‎Result)
Line 38: Line 38:
  
 
<t2b index="Disease,Response metric,Exposure route,Exposure metric,Exposure unit,Threshold,ERF parameter,Observation" locations="ERF,Description" unit="?">
 
<t2b index="Disease,Response metric,Exposure route,Exposure metric,Exposure unit,Threshold,ERF parameter,Observation" locations="ERF,Description" unit="?">
−
CHD|Mortality|Ingestion|Intake|mg/day||ERS|-0.002 (±3.97*10^-4)|Gradowska 2013
+
CHD|Δlog(CHD mortality rate)|Ingestion|Intake from fish|mg/day EPA+DHA||ERS|-0.002 (±3.97E-4)|Moza�ffarian and Rimm 2006; Gradowska 2013
 
  </t2b>
 
  </t2b>
  

Revision as of 11:20, 6 February 2014




Scope

ERF of omega-3 fatty acids on CVD risk in adults describes quantitative relationship between exposure to omega-3 fatty acids and risk of cardiovascular disease (CVD) in adults.

Definition

ERF of omega-3 fatty acids on CVD risk in adults is represented as a random variable. It is indexed by variable age. It applies to the last two age categories of the Beneris population, i.e. adults aged 18-55yr and 55yr+ (gender combined).

Causality

List of parents:

Data

Fernandez-Jarne et al. [1] examined the relationship between intake of fish and n-3 PUFA and the risk of first acute myocardial infarction (AMI) in a low risk population from Navarre (Spain). They found that the n-3 PUFA intake has a protective effect on AMI. The adjusted odds ratio (OR) for the second and third tertile of n-3 PUFA intake were 0.44 (95% Cl, 0.21-0.91) and 0.47 (95% Cl, 0.22-1.00), respectively. The trend test was not statistically significant. D↷

Mozaffarian and Rimm [2] estimated that at intakes between 0 and 250 mg/d, the relative risk of coronary heart disease (CHD) death is lower by 14.6% (95% CI: 8% to 21%) per each 100 mg/d of EPA and DHA intake and that at higher intakes ( > 250 mg/d) the risk reduction is 0.0% (95% CI: -0.9% to 0.8%) per each 100 mg/d.

The ERF of omega-3 fatty acids (DHA+EPA) intake from fish (in unit of mg/kg bw-day) on the CHD mortality is estimated based on information provided in [2]. First, the central estimate and the 95% CI for the change (in this case decrease) in natural logarithm of relative risk (RR) of CHD mortality per unit change in omega-3 fatty acids intake (in unit of mg/day) in both intake intervals were derived. In general, the relationship between the percent change in RR (%RR) associated with c-unit increase in omega-3 fatty acids intake and the incremental change in lnRR (beta) per unit change in omega-3 fatty acids intake is beta = (1/c)*ln((%RR/100)+1). Normal distribution was chosen to describe the uncertainty in the parameter of the log-linear model for RR in each intake interval. For intake of EPA+DHA between 0 and 250 mg/day the mean and the standard deviation of parameter distribution are -0.0016 and 0.0004, for higher intakes 0 and 0.0005. Then, the distribution of ERF of omega-3 fatty acids intake from fish in units of mg/kg bw-day was obtained by multiplying ERFs of omega-3 fatty acids intake measured in mg/day by the body weight of adult.

Unit

lnRR/ 1 (mg/kg bw-day) change in EPA+DHA intake from fish

Formula

For intakes of EPA+DHA from fish between 0 and 250 mg/day: N(-0.0016,0.0004)*BW
For intakes of EPA+DHA from fish higher than 250 mg/day: N(0,0.0005)*BW

Result


Difference between revisions of "ERF of omega-3 fatty acids on CVD risk in adults"(?)
ObsDiseaseResponse metricExposure routeExposure metricExposure unitThresholdERF parameterERFDescription
1CHDΔlog(CHD mortality rate)IngestionIntake from fishmg/day EPA+DHAERS-0.002 (±3.97E-4)Moza�ffarian and Rimm 2006; Gradowska 2013

References


  1. ↑ Fernandez-Jarne E, Garrido FA, Gutierrez AA, Arrillaga CDF, Martinez-Gonzales MA. Dietary intake of n-3 fatty acids and the risk of acute myocardial infarction: a case-control study. (In Spanish) 2002;118:121–5.
  2. ↑ 2.0 2.1 Mozaffarian D., Rimm E.B., Fish intake, contaminants, and human health. Evaluating the risks and the benefits. (Reprinted) JAMA, 2006. Vol 296, No. 15
Retrieved from "http://www.opasnet.org/testiwiki/index.php?title=ERF_of_omega-3_fatty_acids_on_CVD_risk_in_adults&oldid=31484"